Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.170
+0.020 (1.74%)
At close: Oct 27, 2026, 4:00 PM EDT
1.150
-0.020 (-1.71%)
After-hours: Oct 27, 2026, 7:30 PM EDT
Gain Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
51.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 55.18K | -84.93K | -60.62% |
| Dec 31, 2022 | 140.11K | -24.89K | -15.08% |
| Dec 31, 2021 | 164.99K | 136.11K | 471.29% |
| Dec 31, 2020 | 28.88K | -12.42K | -30.07% |
| Dec 31, 2019 | 41.30K | 20.69K | 100.40% |
| Dec 31, 2018 | 20.61K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xilio Therapeutics | 64.09M |
| Werewolf Therapeutics | 21.00M |
| MindWalk Holdings | 11.57M |
| Caribou Biosciences | 10.04M |
| Alps Group | 3.74M |
| Connect Biopharma Holdings | 2.95M |
| iBio, Inc. | 100.00K |
GANX News
- 14 days ago - Sibylla Biotech Appoints Usman Azam CEO, Gianluca Fuggetta CFO, and Expands Executive Team to Drive Transition to Clinic - GlobeNewsWire
- 19 days ago - Gain Therapeutics to Attend the 2026 Maxim Growth Summit - GlobeNewsWire
- 26 days ago - Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration - GlobeNewsWire
- 4 weeks ago - Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson's Disease and Movement Disorders - GlobeNewsWire
- 5 weeks ago - Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference - GlobeNewsWire
- 2 months ago - Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Gain Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Gain Therapeutics Quarterly report: Q2 2026 - Filings